Reviewer: LI Wen-yu, CHEN Fei-li. Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005
|
Citation:
|
Reviewer: LI Wen-yu, CHEN Fei-li. Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005
|
Reviewer: LI Wen-yu, CHEN Fei-li. Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005
|
Citation:
|
Reviewer: LI Wen-yu, CHEN Fei-li. Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005
|
DownLoad: